J Korean Breast Cancer Soc.
1998 Dec;1(2):215-225. 10.4048/jkbcs.1998.1.2.215.
Immunohistochemical Expression of c-erbB2, c-erbB3 and c-erbB4 Protein in Breast Cancer
- Affiliations
-
- 1Department General Surgery, Yonsei University, College of Medicine, Seoul, Korea.
- 2Department Internal Medicine, Yonsei University, College of Medicine, Seoul, Korea.
- 3Department Radiation oncology, Yonsei University, College of Medicine, Seoul, Korea.
- 4Department Pathology, Yonsei University, College of Medicine, Seoul, Korea.
- KMID: 2173680
- DOI: http://doi.org/10.4048/jkbcs.1998.1.2.215
Abstract
- Breast cancer is the third leading cause of cancer related deaths in Korean women. Members of the erbB receptor family, the EGF receptor and c-erbB2, c-erbB3 and c-erbB4, are commonly over-expressed in human breast cancer and there is a high correlation with an aggressive breast cancer phenotype and poor patient prognosis. Since the over-expression of the EGF receptor and c-erbB2 suggested that signalling of erbB receptors may contribute to the development and progression of breast cancer, we investigated the correlation of clinicopathological factors and the immunohistochemical expression of c-erbB2, c-erbB3 and c-erbB4. To determine the c-erbB immunoreactivity, we used Rabbit anti-human c-erbB2 oncoprotein (DAKO, Denmark), mouse monoclonal c-erbB3(RTJ.2 Santa Cruz) and rabbit polyclonal antibody c-erbB4(Santa Cruz) directed against each c-erbB protein by immunohistochemistry from paraffin-embedded tissue in a series of 190 women with breast cancer. About 25.8%(49 out of 190 patients) of breast cancers overxpressed c-erbB2, and 40.0%(76 out of 190 patients) and 18.9%(36 out of 190 patients) overxpressed c-erbB and c-erbB4, respectively. Poor histologic grade showed tendency of positive correlation of the positivity of c-erbB2 and 3 but without statistical significance and no correlation with c-erbB4. We observed positive correlations among c-erbB2, c-erbB3 and c-erbB4 expression.(p<0.05) Estrogen receptors (ER) showed incerse correlations with c-erbB2(p=0.001), c-erbB3(p=0.043) and c-erbB4(p=0.197) and progesterone receptors also showed invers correlation with c-erbB(p=0.018). Tumor size (p>0.05) and lymph node status(p>0.05) were not related with c-erbB family expression. The expressions of c-erbB2, c-erbB3 and c-erbB4 showed no survival benefit or no disease free benefit compared to c-erbB family negativity in univariate analysis (Kaplan-Meier life table analysis). Our results suggest that c-erbB2, c-erbB3, and c-erbB4 may regulate the growth of breast cancer by the interactions of these family of growth factor receptor that are dependent of hormonal control.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Expression of Heregulin and ErbB Family Proteins in Gastric Adenocarcinomas: Correlation with Clinopathologic Prognostic Factors
- Inorganic sulfur reduces cell proliferation by inhibiting of ErbB2 and ErbB3 protein and mRNA expression in MDA-MB-231 human breast cancer cells
- Role of Shc and phosphoinositide 3-kinase in heregulin-induced mitogenic signaling via ErbB3
- Radish (Raphanus sativus L. leaf) ethanol extract inhibits protein and mRNA expression of ErbB2 and ErbB3 in MDA-MB-231 human breast cancer cells
- Delphinidin inhibits cell proliferation and induces apoptosis in MDA-MB-231 human breast cancer cell lines
